BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Neag EJ, Smith TJ. 2021 update on thyroid-associated ophthalmopathy. J Endocrinol Invest 2021. [PMID: 34417736 DOI: 10.1007/s40618-021-01663-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang P, Zhu H. Cytokines in Thyroid-Associated Ophthalmopathy. Journal of Immunology Research 2022;2022:1-12. [DOI: 10.1155/2022/2528046] [Reference Citation Analysis]
2 Li R, Li J, Wang Z. Thyroid-associated ophthalmopathy: Using diffusion tensor imaging to evaluate visual pathway microstructural changes. Front Neurol 2022;13. [DOI: 10.3389/fneur.2022.1025666] [Reference Citation Analysis]
3 Zhou J, Yu X, Lou Y, Bao J, Xia Y, Zhu L, Tang M. Detection and Correlation Analysis of Serum Uric Acid in Patients with Thyroid-Associated Ophthalmopathy. Computational and Mathematical Methods in Medicine 2022;2022:1-6. [DOI: 10.1155/2022/8406834] [Reference Citation Analysis]
4 Tang C, Liang L, Zheng X, Hu H, Liu C, Long J. Glucocorticoid therapy reduces ocular hypertension in active moderate-severe thyroid-associated orbitopathy. BMC Endocr Disord 2022;22:235. [PMID: 36151558 DOI: 10.1186/s12902-022-01153-w] [Reference Citation Analysis]
5 Diao J, Chen X, Mou P, Ma X, Wei R. Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts. Invest Ophthalmol Vis Sci 2022;63:6. [PMID: 36094643 DOI: 10.1167/iovs.63.10.6] [Reference Citation Analysis]
6 Gao Y, Li W. Mechanisms of immune-related differentially expressed genes in thyroid-associated ophthalmopathy based on the GEO database. Ann Transl Med 2022;10:926. [PMID: 36172114 DOI: 10.21037/atm-22-3470] [Reference Citation Analysis]
7 Cheng S, Ming Y, Hu M, Zhang Y, Jiang F, Wang X, Xiao Z. Risk prediction of dysthyroid optic neuropathy based on CT imaging features combined the bony orbit with the soft tissue structures. Front Med 2022;9. [DOI: 10.3389/fmed.2022.936819] [Reference Citation Analysis]
8 Ma R, Gan L, Guo J, Peng Z, Wu J, Harrison AR, Qian J. Insights Into Ferroptosis: Targeting Glycolysis to Treat Graves' Orbitopathy. J Clin Endocrinol Metab 2022;107:1994-2003. [PMID: 35303084 DOI: 10.1210/clinem/dgac163] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Hsu C, Hsieh M, Chang H, Chen Y, Chien K. Improvement of Ocular Surface Disease by Lateral Tarsoconjunctival Flap in Thyroid-Associated Orbitopathy Patients with Lid Retraction. JPM 2022;12:802. [DOI: 10.3390/jpm12050802] [Reference Citation Analysis]
10 Xiao Z, Murakhovskaya I. Development of New Drugs for Autoimmune Hemolytic Anemia. Pharmaceutics 2022;14:1035. [DOI: 10.3390/pharmaceutics14051035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Rui L, Jing L, Zhenchang W. Diffusion Tensor Imaging Technology to Quantitatively Assess Abnormal Changes in Patients With Thyroid-Associated Ophthalmopathy. Front Hum Neurosci 2022;15:805945. [DOI: 10.3389/fnhum.2021.805945] [Reference Citation Analysis]
12 Franchini F, Palatucci G, Colao A, Ungaro P, Macchia PE, Nettore IC. Obesity and Thyroid Cancer Risk: An Update. Int J Environ Res Public Health 2022;19:1116. [PMID: 35162142 DOI: 10.3390/ijerph19031116] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Bartalena L, Piantanida E, Tanda ML. Statins for Graves' orbitopathy: a new tool for prevention and treatment? Lancet Diabetes Endocrinol 2021;9:726-7. [PMID: 34592165 DOI: 10.1016/S2213-8587(21)00268-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]